AAAAAA
Results:
1-12
|
Results: 12
Authors:
Milicevic, Z
Profozic, V
Wyatt, J
Ristic, S
Woodworth, JR
Seger, M
Kaliterna, D
Bates, P
Metelko, Z
Citation: Z. Milicevic et al., Intramuscular injection of insulin lispro or soluble human insulin: pharmacokinetics and glucodynamics in Type 2 diabetes, DIABET MED, 18(7), 2001, pp. 562-566
Authors:
Woodworth, JR
Riley, ME
Arnatucci, VA
Hamilton, TW
Aragon, BP
Citation: Jr. Woodworth et al., Absolute intensities of the vacuum ultraviolet spectra in oxide etch plasma processing discharges, J VAC SCI A, 19(1), 2001, pp. 45-55
Authors:
Malone, JK
Yang, H
Woodworth, JR
Huang, J
Campaigne, BN
Halle, JP
Yale, JF
Grossman, LD
Citation: Jk. Malone et al., Humalog (R) Mix25 (TM) offers better mealtime glycemic control in patientswith type 1 or type 2 diabetes, DIABETE MET, 26(6), 2000, pp. 481-487
Authors:
Ouellet, D
Periclou, AP
Johnson, RD
Woodworth, JR
Lalonde, RL
Citation: D. Ouellet et al., Population pharmacokinetics of pemetrexed disodium (ALIMTA) in patients with cancer, CANC CHEMOT, 46(3), 2000, pp. 227-234
Authors:
Malone, JK
Woodworth, JR
Arora, V
Yang, HC
Campaigne, BN
Halle, JP
Yale, JF
Grossman, LD
Citation: Jk. Malone et al., Improved postprandial glycemic control with Humalog (R) Mix75/25 (TM) after a standard test meal in patients with type 2 diabetes mellitus, CLIN THER, 22(2), 2000, pp. 222-230
Authors:
Chen, WJ
Abraham-Shrauner, B
Woodworth, JR
Citation: Wj. Chen et al., Model etch profiles for ion energy distribution functions in an inductively coupled plasma reactor, J VAC SCI B, 17(5), 1999, pp. 2061-2069
Authors:
Woodworth, JR
Blain, MG
Jarecki, RL
Hamilton, TW
Aragon, BP
Citation: Jr. Woodworth et al., Absolute intensities of the vacuum ultraviolet spectra in a metal-etch plasma processing discharge, J VAC SCI A, 17(6), 1999, pp. 3209-3217
Authors:
Rinaldi, DA
Kuhn, JG
Burris, HA
Dorr, FA
Rodriguez, G
Eckhardt, SG
Jones, S
Woodworth, JR
Baker, S
Langley, C
Mascorro, D
Abrahams, T
Von Hoff, DD
Citation: Da. Rinaldi et al., A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation, CANC CHEMOT, 44(5), 1999, pp. 372-380
Authors:
Rave, K
Heinemann, L
Puhl, L
Gudat, U
Woodworth, JR
Weyer, C
Heise, T
Citation: K. Rave et al., Premixed formulations of insulin lispro, DIABET CARE, 22(5), 1999, pp. 865-866
Authors:
Graf, CJ
Woodworth, JR
Seger, ME
Holcombe, JH
Bowsher, RR
Lynch, R
Citation: Cj. Graf et al., Pharmacokinetic and glucodynamic comparisons of recombinant and animal-source glucagon after IV, IM, and SC injection in healthy volunteers, J PHARM SCI, 88(10), 1999, pp. 991-995
Authors:
Bowsher, RR
Lynch, RA
Brown-Augsburger, P
Santa, PF
Legan, WE
Woodworth, JR
Chance, RE
Citation: Rr. Bowsher et al., Sensitive RIA for the specific determination of insulin lispro, CLIN CHEM, 45(1), 1999, pp. 104-110
Authors:
Blain, MG
Stevens, JE
Woodworth, JR
Citation: Mg. Blain et al., High-resolution submicron retarding field energy analyzer for low-temperature plasma analysis, APPL PHYS L, 75(25), 1999, pp. 3923-3925
Risultati:
1-12
|